Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ... Neurology 65 (12), 1863-1872, 2005 | 8659* | 2005 |
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission G Livingston, J Huntley, A Sommerlad, D Ames, C Ballard, S Banerjee, ... The lancet 396 (10248), 413-446, 2020 | 7017 | 2020 |
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science EA Holmes, RC O'Connor, VH Perry, I Tracey, S Wessely, L Arseneault, ... The lancet psychiatry 7 (6), 547-560, 2020 | 6554 | 2020 |
Dementia prevention, intervention, and care G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ... The lancet 390 (10113), 2673-2734, 2017 | 6091 | 2017 |
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop IG McKeith, D Galasko, K Kosaka, EK Perry, DW Dickson, LA Hansen, ... Neurology 47 (5), 1113-1124, 1996 | 4813 | 1996 |
Alzheimer's disease C Ballard, S Gauthier, A Corbett, C Brayne, D Aarsland, E Jones the Lancet 377 (9770), 1019-1031, 2011 | 3239 | 2011 |
Vascular cognitive impairment J T O'Brien, T Erkinjuntti, B Reisberg, G Roman, T Sawada, L Pantoni, ... The Lancet Neurology 2 (2), 89-98, 2003 | 1984 | 2003 |
Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1821 | 2016 |
Putting brain training to the test AM Owen, A Hampshire, JA Grahn, R Stenton, S Dajani, AS Burns, ... Nature 465 (7299), 775-778, 2010 | 1627 | 2010 |
Cognitive decline in Parkinson disease D Aarsland, B Creese, M Politis, KR Chaudhuri, DH Ffytche, D Weintraub, ... Nature Reviews Neurology 13 (4), 217-231, 2017 | 1011 | 2017 |
Donepezil and memantine for moderate-to-severe Alzheimer's disease R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ... New England Journal of Medicine 366 (10), 893-903, 2012 | 919 | 2012 |
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease CG Ballard, J Waite, J Birks Cochrane Database of Systematic Reviews, 2006 | 868 | 2006 |
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial C Ballard, ML Hanney, M Theodoulou, S Douglas, R McShane, ... The Lancet Neurology 8 (2), 151-157, 2009 | 770 | 2009 |
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial J Cummings, S Isaacson, R Mills, H Williams, K Chi-Burris, A Corbett, ... The Lancet 383 (9916), 533-540, 2014 | 736 | 2014 |
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial J Fossey, C Ballard, E Juszczak, I James, N Alder, R Jacoby, R Howard Bmj 332 (7544), 756-761, 2006 | 721 | 2006 |
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa CG Ballard, JT O'Brien, K Reichelt, EK Perry Journal of clinical Psychiatry 63 (7), 553-558, 2002 | 698 | 2002 |
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial BS Husebo, C Ballard, R Sandvik, OB Nilsen, D Aarsland Bmj 343, 2011 | 663 | 2011 |
Depression in Parkinson disease—epidemiology, mechanisms and management D Aarsland, S Påhlhagen, CG Ballard, U Ehrt, P Svenningsson Nature Reviews Neurology 8 (1), 35-47, 2012 | 658 | 2012 |
Overlap between pathology of Alzheimer disease and vascular dementia RN Kalaria, C Ballard Alzheimer Disease & Associated Disorders 13, S115-S123, 1999 | 658 | 1999 |
Parkinson disease-associated cognitive impairment D Aarsland, L Batzu, GM Halliday, GJ Geurtsen, C Ballard, ... Nature Reviews Disease Primers 7 (1), 1-21, 2021 | 652 | 2021 |